BridgeMD
New treatment option for Critical Ill Patients
Official title Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
ClinicalTrials.gov ID: NCT06843668
What this study is testing
What is EMA colistin dosing strategy?
EMA colistin dosing strategy is an investigational medicine, given as an once-daily, being studied as a potential treatment for critical ill patients.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Nosocomial infections caused by multi-drug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative pathogens represent a major threat worldwide. The increasing trend of multi-drug resistance in Gram-negative bacteria (MDR-GNB) poses a particularly acute challenge to health systems especially in critically ill patients.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients age ≥ 18 years old.
- Patients who will be treated with CMS for MR GNB infections.
- Patients who are admitted to the ICUs.
You likely can't join if
- Known hypersensitivity to colistin.
- Pregnant and lactating women.
- Patients who are treated with colistin for \< 24 hours.
- Patients with myasthenia gravis or concomitant anesthetics or neuromuscular blocking drugs.
The study team makes the final eligibility decision.
Where it's taking place
- Buraidah, Saudi Arabia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Buraidah, Saudi Arabia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.